Experienced Scientists for Your Metabolic Disease Program
A Powerful Consultative Partnership Aids Translational Sciences
Whether you are assessing target-based, mechanism-based, or disease-based biomarkers, formulating the most effective biomarker strategy can be a challenge. Our seasoned scientists will collaborate with you to decide which inflammatory pathway to investigate, and how to go about it.
Early Engagement Facilitates Clean Go-No-Go Decisions
What biomarkers suit your trial, what are your exploratory endpoints, and might your cohort provide additional insights? Our experience working with metabolic diseases and mechanisms streamlines your programs and increases the probability of success.
Latest Biomarkers, Selected for Utility
To identify emerging candidate biomarkers that probe specific pathways and mechanisms relevant to our clients, our team is constantly monitoring the literature. We onboard the emerging biomarkers we judge most likely to enhance your metabolic disease research.